PortfoliosLab logoPortfoliosLab logo
TCOM vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TCOM vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trip.com Group Limited (TCOM) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TCOM achieves a -40.48% return, which is significantly lower than GMED's -10.54% return. Over the past 10 years, TCOM has underperformed GMED with an annualized return of 0.25%, while GMED has yielded a comparatively higher 12.07% annualized return.


TCOM

1D
3.31%
1M
-9.69%
6M
-43.43%
YTD
-40.48%
1Y
-30.88%
3Y*
6.23%
5Y*
5.97%
10Y*
0.25%

GMED

1D
1.92%
1M
-2.99%
6M
-17.32%
YTD
-10.54%
1Y
36.75%
3Y*
8.91%
5Y*
-0.63%
10Y*
12.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TCOM vs. GMED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TCOM
Trip.com Group Limited
-40.48%5.24%90.67%4.68%39.72%-27.01%0.57%23.95%-38.64%10.25%
GMED
Globus Medical, Inc.
-10.54%5.56%55.21%-28.25%2.87%10.70%10.77%36.04%5.30%65.66%

Correlation

The correlation between TCOM and GMED is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Aug 3, 2012

0.22

The correlation between TCOM and GMED shifts across timeframes, from 0.08 (1 year) to 0.23 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TCOM:

$26.95B

GMED:

$10.53B

EPS

TCOM:

CN¥45.41

GMED:

$4.28

PE Ratio

TCOM:

6.39

GMED:

18.23

PEG Ratio

TCOM:

0.04

GMED:

0.19

PS Ratio

TCOM:

3.12

GMED:

3.45

PB Ratio

TCOM:

1.20

GMED:

2.28

Total Revenue (TTM)

TCOM:

CN¥64.48B

GMED:

$3.10B

Gross Profit (TTM)

TCOM:

CN¥51.79B

GMED:

$1.58B

EBITDA (TTM)

TCOM:

CN¥39.20B

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TCOM vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCOM
TCOM Risk / Return Rank: 1414
Overall Rank
TCOM Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
TCOM Sortino Ratio Rank: 1313
Sortino Ratio Rank
TCOM Omega Ratio Rank: 1111
Omega Ratio Rank
TCOM Calmar Ratio Rank: 2121
Calmar Ratio Rank
TCOM Martin Ratio Rank: 1515
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 7373
Overall Rank
GMED Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 7575
Sortino Ratio Rank
GMED Omega Ratio Rank: 7272
Omega Ratio Rank
GMED Calmar Ratio Rank: 7575
Calmar Ratio Rank
GMED Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCOM vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trip.com Group Limited (TCOM) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TCOMGMEDDifference
Sharpe ratioReturn per unit of total volatility

-1.53

Sortino ratioReturn per unit of downside risk

-2.76

Omega ratioGain probability vs. loss probability

0.85

1.21

-0.35

Calmar ratioReturn relative to maximum drawdown

-0.62

1.60

-2.22

Martin ratioReturn relative to average drawdown

-1.24

3.87

-5.10

TCOM vs. GMED - Sharpe Ratio Comparison

The current TCOM Sharpe Ratio is -0.81, which is lower than the GMED Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of TCOM and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TCOM vs. GMED - Drawdown Comparison

The maximum TCOM drawdown since its inception was -76.34%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for TCOM and GMED.


Loading charts...

Drawdown Indicators


TCOMGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-76.34%

-47.91%

-28.43%

Max Drawdown (1Y)

Largest decline over 1 year

-49.54%

-22.10%

-27.44%

Max Drawdown (3Y)

Largest decline over 3 years

-49.54%

-44.40%

-5.14%

Max Drawdown (5Y)

Largest decline over 5 years

-49.54%

-47.91%

-1.63%

Max Drawdown (10Y)

Largest decline over 10 years

-71.96%

-47.91%

-24.05%

Current Drawdown

Current decline from peak

-45.80%

-19.32%

-26.48%

Average Drawdown

Average peak-to-trough decline

-27.89%

-15.33%

-12.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.98%

9.13%

+15.85%

Volatility

TCOM vs. GMED - Volatility Comparison

Trip.com Group Limited (TCOM) has a higher volatility of 16.28% compared to Globus Medical, Inc. (GMED) at 13.69%. This indicates that TCOM's price experiences larger fluctuations and is considered to be riskier than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TCOMGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.28%

13.69%

+2.59%

Volatility (6M)

Calculated over the trailing 6-month period

31.02%

25.33%

+5.69%

Volatility (1Y)

Calculated over the trailing 1-year period

38.00%

49.46%

-11.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

49.47%

38.27%

+11.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.42%

35.68%

+8.74%

Dividends

TCOM vs. GMED - Dividend Comparison

Neither TCOM nor GMED has paid dividends to shareholders.


PositionTTM2025
GMED
Globus Medical, Inc.
0.00%0.00%
TCOM
Trip.com Group Limited
0.00%0.42%

Financials

TCOM vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between Trip.com Group Limited and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
16.11B
759.85M
(TCOM) Total Revenue
(GMED) Total Revenue
Please note, different currencies. TCOM values in CNY, GMED values in USD

TCOM vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Trip.com Group Limited and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
79.5%
0
Portfolio components
TCOM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Trip.com Group Limited reported a gross profit of 12.80B and revenue of 16.11B. Therefore, the gross margin over that period was 79.5%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

TCOM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Trip.com Group Limited reported an operating income of 3.92B and revenue of 16.11B, resulting in an operating margin of 24.3%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

TCOM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Trip.com Group Limited reported a net income of 2.48B and revenue of 16.11B, resulting in a net margin of 15.4%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


TCOM and GMED have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TCOM has higher volatility (16.28%) compared to GMED (13.69%). In terms of maximum drawdown, TCOM dropped -76.34% vs GMED's -47.91%.

GMED currently has the higher Sharpe Ratio (0.71 vs -0.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TCOM and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer